S100A4 and lung cancer: Consistent with these findings, inhibiting S100A4 with small hairpin RNA (shRNA) or Niclosamide impeded nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activity and, subsequently, the expression of MMP9 in various lung cancer cell lines, ultimately curtailing their invasiveness[72].